[EN] SMALL MOLECULE AGONISTS AND ANTAGONISTS OF NR2F6 ACTIVITY<br/>[FR] AGONISTES ET ANTAGONISTES À PETITES MOLÉCULES DE L'ACTIVITÉ DE NR2F6
申请人:REGEN BIOPHARMA INC
公开号:WO2019104199A1
公开(公告)日:2019-05-31
The present technology is directed to modulators of nuclear receptor activity, specifically to the modulation of NR2F6 activity and NR2F6 utilizing compounds, and the immune modulation and modulation of cancer stem cell activity through administration of compounds described herein. In certain embodiments the present disclosure is directed to methods of using small molecule compounds as immune modulators.